Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)
|Incentive Type:||Grant Program|
Health And Safety, Technology, Research, Education,
|Governing Body:||Food & Drug Administration|
|What’s it worth?:||$250,000 – $500,000|
The purpose of the Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant program fund the development of products used to treat rare diseases and conditions that no current therapy methods are available. These efforts are expected to significantly impact the market.
Funds typically do not exceed $250,000 for Phase I projects and $500,000 for Phase II projects. Applicants are encourage to contact the NIH program officials before proposing anything in excess of the guidelines.
Applications must be complete and received before the deadline.